Uric acid and hypertension: insights from the joint symposium

Affiliations

¹ Division of Public Health, Center for Community Medicine, Jichi Medical University, Shimotsuke, Japan. kuwamasa728@gmail.com.
² Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University, Shimotsuke, Japan. kuwamasa728@gmail.com.
³ Department of Cardiology, National Hospital Organization Yonago Medical Center, Yonago, Japan. kuwamasa728@gmail.com.
⁴ Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
⁵ Department of Cardiology, Sanin Rosai Hospital, Yonago, Japan.
⁶ Department of Cardiovascular Medicine, Saga University, Saga, Japan.
⁷ Department of Regenerative Medicine, Division of Radiation Medical Science, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
⁸ Department of Cardiology, National Hospital Organization Yonago Medical Center, Yonago, Japan.
⁹ Division of Hormonal Medicine and Bioregulatory Science, Department of Medicine, Tokyo Women's Medical University, Tokyo, Japan.
¹⁰ Steel Memorial Yawata Hospital, Kitakyushu, Japan.

Masanari Kuwabara et al. Hypertens Res. 2025 Jun.

. 2025 Jun;48(6):2009-2011.

doi: 10.1038/s41440-025-02192-1. Epub 2025 Mar 21.

¹ Division of Public Health, Center for Community Medicine, Jichi Medical University, Shimotsuke, Japan. kuwamasa728@gmail.com.
² Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University, Shimotsuke, Japan. kuwamasa728@gmail.com.
³ Department of Cardiology, National Hospital Organization Yonago Medical Center, Yonago, Japan. kuwamasa728@gmail.com.
⁴ Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
⁵ Department of Cardiology, Sanin Rosai Hospital, Yonago, Japan.
⁶ Department of Cardiovascular Medicine, Saga University, Saga, Japan.
⁷ Department of Regenerative Medicine, Division of Radiation Medical Science, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
⁸ Department of Cardiology, National Hospital Organization Yonago Medical Center, Yonago, Japan.
⁹ Division of Hormonal Medicine and Bioregulatory Science, Department of Medicine, Tokyo Women's Medical University, Tokyo, Japan.
¹⁰ Steel Memorial Yawata Hospital, Kitakyushu, Japan.

No abstract available

Keywords: Cardiovascular disease; Hypertension; Hyperuricemia; Implementation; Uric acid.

Conflict of interest statement

Compliance with ethical standards. Conflict of interest: The authors declare no competing interests.

1. Kario K, Nishiyama A, Shibata S, Arima H, Furuhashi M, Ichihara A, et al. Digital hypertension, implementation hypertension, and internationalization - 3 pillars of Japanese Society of Hypertension 2024-2026 advancing hypertension science from Japan to the world in the information network era. Hypertens Res. 2025;48:1–5. - DOI - PubMed
1. Gois PHF, Souza ERM. Pharmacotherapy for hyperuricaemia in hypertensive patients. Cochrane Database Syst Rev. 2020;9:CD008652. - PubMed
1. Maruhashi T, Kajikawa M, Kishimoto S, Yamaji T, Harada T, Mizobuchi A, et al. Serum uric acid is independently associated with impaired nitroglycerine-induced vasodilation of the brachial artery in women. Hypertens Res. 2025;48:6–14. - DOI - PubMed
1. Gill D, Cameron AC, Burgess S, Li X, Doherty DJ, Karhunen V, et al. Urate, Blood Pressure, and Cardiovascular Disease: Evidence From Mendelian Randomization and Meta-Analysis of Clinical Trials. Hypertension. 2021;77:383–92. - DOI - PubMed
1. Kuwabara M, Kodama T, Ae R, Kanbay M, Andres-Hernando A, Borghi C, et al. Update in uric acid, hypertension, and cardiovascular diseases. Hypertens Res. 2023;46:1714–26. - DOI - PubMed